[/(
An/DT
overexpression/NN
of/IN
retinoic/JJ
acid/NN
receptor/NN
alpha/NN
blocks/VBZ
myeloid/JJ
cell/NN
differentiation/NN
at/IN
the/DT
promyelocyte/JJ
stage/NN
]/)

Retinoic/JJ
acid/NN
(/(
RA/NN
)/)
,/,
a/DT
vitamin/NN
A/NN
derivative/JJ
,/,
exerts/VBZ
a/DT
wide/JJ
range/NN
of/IN
biological/JJ
effects/NNS
related/JJ
to/TO
cell/NN
proliferation/NN
and/CC
differentiation/NN
./.
=====
The/DT
pleiotropic/JJ
effects/NNS
of/IN
RA/NN
are/VBP
thought/VBN
to/TO
be/VB
mediated/VBN
through/IN
specific/JJ
nuclear/JJ
RA/NN
receptors/NNS
(/(
RARs/NNS
)/)
./.
=====
RARs/NNS
are/VBP
members/NNS
of/IN
the/DT
steroid/thyroid/NN
hormone/NN
receptor/NN
superfamily/NN
and/CC
exhibit/VBP
a/DT
molecular/JJ
structure/NN
that/WDT
possess/VBP
discrete/JJ
DNA-binding/JJ
and/CC
RA/NN
(/(
ligand/NN
)/)
-binding/JJ
domains/NNS
./.
=====
In/IN
hematopoietic/JJ
system/NN
,/,
RA/NN
and/CC
RARs/NNS
,/,
predominantly/RB
RAR/NN
alpha/NN
may/MD
play/VB
key/JJ
roles/NNS
for/IN
the/DT
proliferation/NN
and/CC
differentiation/NN
of/IN
hematopoietic/JJ
progenitors/NNS
./.
=====
However/RB
,/,
it/PRP
is/VBZ
currently/RB
unknown/JJ
how/WRB
RA/NN
and/CC
RARs/NNS
are/VBP
involved/VBN
in/IN
regulating/VBG
normal/JJ
hematopoietic/JJ
differentiation/NN
./.
=====
To/TO
make/VB
clear/JJ
the/DT
roles/NNS
of/IN
RA/NN
and/CC
RAR/NN
alpha/NN
in/IN
the/DT
normal/JJ
hematopoiesis/NN
,/,
I/PRP
have/VBP
introduced/VBN
the/DT
construct/NN
of/IN
human/JJ
RAR/NN
alpha/NN
(/(
hRAR/NN
alpha/NN
)/)
into/IN
murine/NN
bone/NN
marrow/NN
cells/NNS
with/IN
retroviral/JJ
vector/NN
,/,
and/CC
selected/VBN
infected/JJ
cells/NNS
with/IN
drug/NN
resistant/JJ
marker/NN
(/(
Neo(r)/NN
)/)
cultured/VBN
on/IN
the/DT
stroma/NN
cell/NN
line/NN
(/(
PA6-neo/JJ
)/)
,/,
and/CC
analyzed/VBN
the/DT
behavior/NN
of/IN
infected/JJ
cells/NNS
./.
=====
All/DT
of/IN
procedure/NN
were/VBD
done/VBN
in/FW
vitro/FW
./.
=====
Most/JJS
cells/NNS
infected/VBN
with/IN
hRAR/NN
alpha/NN
exhibited/VBD
promyelocytic/JJ
morphology/NN
and/CC
were/VBD
thought/VBN
to/TO
be/VB
blocked/VBN
at/IN
the/DT
promyelocytic/JJ
stage/NN
in/IN
their/PRP$
myeloid/JJ
differentiation/NN
./.
=====
Furthermore/RB
,/,
these/DT
immature/JJ
cells/NNS
differentiated/VBD
terminally/RB
into/IN
mature/JJ
granulocytes/NNS
by/IN
adding/VBG
with/IN
RA/NN
(/(
10/CD
(/(
-6/CD
)/)
M/NN
)/)
./.
=====
RAR/NN
alpha/NN
infected/JJ
cells/NNS
were/VBD
also/RB
able/JJ
to/TO
differentiate/VB
into/IN
mature/JJ
macrophages/NNS
in/IN
the/DT
both/CC
of/IN
long/JJ
term/NN
culture/NN
and/CC
IL3/NN
colony/NN
./.
=====
These/DT
observations/NNS
suggest/VBP
that/IN
an/DT
overexpression/NN
of/IN
RAR/NN
alpha/NN
alone/RB
is/VBZ
effective/JJ
to/TO
suppress/VB
myeloid/JJ
cell/NN
differentiation/NN
and/CC
RAR/NN
alpha/NN
plays/VBZ
a/DT
crucial/JJ
role/NN
in/IN
the/DT
terminal/JJ
differentiation/NN
of/IN
myeloid/JJ
precursors/NNS
./.
=====
The/DT
system/NN
described/VBN
here/RB
may/MD
serve/VB
as/IN
a/DT
model/NN
for/IN
studying/VBG
the/DT
the/DT
essential/JJ
genes/NNS
for/IN
differentiation/NN
of/IN
normal/JJ
bone/NN
marrow/NN
cells/NNS
./.